UBS Group’s NextCure NXTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.66K | Buy |
|
|||||
|
2025
Q1 | $4.1K | Buy |
|
|||||
|
2024
Q4 | $3.24K | Sell |
|
|||||
|
2024
Q3 | $7.49K | Sell |
|
|||||
|
2024
Q2 | $15.8K | Sell |
|
|||||
|
2024
Q1 | $24.1K | Buy |
|
|||||
|
2023
Q4 | $7.14K | Sell |
|
|||||
|
2023
Q3 | $15.1K | Sell |
|
|||||
|
2023
Q2 | $28.2K | Buy |
|
|||||
|
2023
Q1 | $18.9K | Buy |
|
|||||
|
2022
Q4 | $15K | Buy |
|
|||||
|
2022
Q3 | $27K | Buy |
|
|||||
|
2022
Q2 | $44K | Buy |
|
|||||
|
2022
Q1 | $45K | Buy |
|
|||||
|
2021
Q4 | $17K | Buy |
|
|||||
|
2021
Q3 | $0 | Buy |
|
|||||
|
2021
Q2 | $0 | Sell |
|
|||||
|
2021
Q1 | $21K | Sell |
|
|||||
|
2020
Q4 | $84K | Buy |
|
|||||
|
2020
Q3 | $0 | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $339K | Buy |
|
|||||
|
2019
Q4 | $31K | Sell |
|
|||||
|
2019
Q3 | $75K | Buy |
|
|||||
|
2019
Q2 | $22K | Buy |
|